The developed HER2-targeted DNA aptamer was labeled with the near-infrared (NIR) fluorescent dye IRD800CW, enabling its use for optical imaging or targeted HER2 therapy in patients with HER2-overexpressed cancers. The gene discussed is ERBB2; the disease is cancer.